Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

GAO Finds Hemophilia Rx Reimbursement Follows Familiar AWP Pattern

Executive Summary

Hemophilia treatment centers purchase blood clotting factor from manufacturers at prices 35% to 48% below AWP, a General Accounting Office report states

You may also be interested in...



Senate AWP Plan Directs HHS To Determine “Market Price” For Chemotherapy

The Senate Finance Committee's Medicare reform bill includes a provision directing HHS to determine actual "market prices" for reimbursement of outpatient drugs currently covered under part B

Senate AWP Plan Directs HHS To Determine “Market Price” For Chemotherapy

The Senate Finance Committee's Medicare reform bill includes a provision directing HHS to determine actual "market prices" for reimbursement of outpatient drugs currently covered under part B

Medicare “Inherent Reasonableness” Standard Should Be Clarified, BIO Says

The Centers for Medicare & Medicaid Services should clarify its guidelines for applying the "inherent reasonableness" standard to coverage decisions, the Biotechnology Industry Organization says

UsernamePublicRestriction

Register

LL1126230

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel